Shanghai EPN and BioMap Reached a Strategic Cooperation

News

}

Home / News / Portfolio Highlights / Portfolio Highlights detail

Time: 2021-05-11

Source: Viva Biotech

[Abstract]:To jointly work on the development of autoimmune diseases therapies

Shanghai, China-Recently, Shanghai EPN, a biotech start-up company invested and incubated by Viva BioInnovator, have reached a strategic cooperation agreement with BioMap to focus on autoimmune diseases cooperative development of multi-omics joint analysis of specific clinical problems and functional omics disease maps of specific diseases.

Previous Page：TechnoDerma Announced New Progress in Phase I Clinical Trials of TDM-105795 in the U.S. Next Page：Anji Pharmaceutical Accelerates Phase II Clinical Study of ANJ908

Back

Media contact: vivapr@vivabiotech.com

This site uses cookies and your privacy choices are important to us

We use cookies to improve the user experience and to analyze website traffic. By clicking "Accept", you consent to the use of cookies on our website, such as cookies policies.